New Key Statistics Module, Z-Score and F-Score
NAS:KRYS Key Ratios
Market Cap $ M | 5,791.38 |
Enterprise Value $ M | 5,239.46 |
P/E(ttm) | 55.08 |
PE Ratio without NRI | 120.56 |
Forward PE Ratio | 91.05 |
Price/Book | 6.90 |
Price/Sales | 35.53 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 311.56 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 166.00 |
EPS (TTM) $ | 3.66 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 45.90 |
EV-to-EBITDA | 43.58 |
PEG | -- |
Shares Outstanding M | 28.73 |
Net Margin (%) | 63.73 |
Operating Margin % | 2.42 |
Pre-tax Margin (%) | 65.20 |
Quick Ratio | 9.33 |
Current Ratio | 9.50 |
ROA % (ttm) | 13.03 |
ROE % (ttm) | 13.85 |
ROIC % (ttm) | 1.63 |
Dividend Yield % | -- |
Altman Z-Score | 45.10 |
KRYS Number of Guru Trades
KRYS Volume of Guru Trades
Gurus Latest Trades with NAS:KRYS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KRYS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Krystal Biotech Inc Insider Transactions
No Available Data
News about NAS:KRYS
Total 0- 1